Product: Pranlukast (hemihydrate)
XPG Antibody Summary
| Immunogen |
Recombinant protein encompassing a sequence within the C-terminus region of human XPG. The exact sequence is proprietary.
|
| Localization |
Nucleus
|
| Isotype |
IgG
|
| Clonality |
Polyclonal
|
| Host |
Rabbit
|
| Gene |
ERCC5
|
| Purity |
Immunogen affinity purified
|
| Innovators Reward |
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
|
Applications/Dilutions
| Dilutions |
|
| Application Notes |
The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
|
| Theoretical MW |
133 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
Packaging, Storage & Formulations
| Storage |
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
|
| Buffer |
PBS (pH 7.0), 1.0% BSA and 20% Glycerol
|
| Preservative |
0.01% Thimerosal
|
| Concentration |
1 mg/ml
|
| Purity |
Immunogen affinity purified
|
Alternate Names for XPG Antibody
- COFS3
- DNA excision repair protein ERCC-5
- DNA repair protein complementing XP-G cells
- EC 3.1
- ERCM2
- excision repair cross-complementing rodent repair deficiency, complementationgroup 5
- excision repair protein
- xeroderma pigmentosum complementation group G protein
- Xeroderma pigmentosum group G-complementing protein
- xeroderma pigmentosum, complementation group G
- XPGC
- XPG-complementing protein
- XPGUVDR
Background
Excision repair cross-complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G) is involved in excision repair of UV-induced DNA damage. Mutations cause Cockayne syndrome, which is characterized by severe growth defects, mental retardation, and cachexia. Multiple alternatively spliced transcript variants encoding distinct isoforms have been described, but the biological validity of all variants has not been determined. [provided by RefSeq]
